| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2022―Mai―08 |
A retrospective analysis of incidence and severity of COVID-19 among hypertensive patients: the other side |
Crhistian-Mario Oblitas, Ana Torres-Do-Rego, Alejandra García García, Víctor Mato-Jimeno, Leyre Alonso González, Sara Luis-García, et al. (+3) Andrés Enríquez-Gómez, Mercedes Baltasar-López, Elena Bello-Martínez |
| 2 |
[GO] |
2022―Mai―08 |
Association between hypertension and prognosis of patients with COVID-19: A systematic review and meta-analysis |
Zhe Qian, Zhuohong Li, Jie Peng, Qiqing Gao, Shaohang Cai, Xuwen Xu |
| 3 |
[GO] |
2022―Mai―05 |
The effect of hypertension and antihypertensive therapies on the course of COVID-19 infection: Turkish national health system data |
Gülsüm Özkan, Şükrü Ulusoy, Yunus Erdem, Bülent Altun, Rahmi Yılmaz, Naim Ata, et al. (+4) Mustafa Mahir Ülgü, Murat Çağlayan, Osman Çelik, Şuayip Birinci |
| 4 |
[GO] |
2022―Jan―07 |
Association Between the Effectiveness and Immunogenicity of Inactivated SARS-CoV2 Vaccine (CoronaVac) with the Presence of Hypertension among Health Care Workers |
Achmad Rifai, Cesarius Singgih Wahono, Mirza Zaka Pratama, Kusworini Handono, Hani Susianti, Agustin Iskandar, et al. (+4) Nurima Diyah, Dewi Santoningsih, Nur Samsu, Atma Gunawan |
| 5 |
[GO] |
2021―Aug―20 |
Renin-angiotensin system modulators in COVID-19 patients with hypertension: friend or foe? |
Shakhi Shylesh C.M, Arya V S, Kanthlal S. K., Uma Devi P. |
| 6 |
[GO] |
2021―Jul―06 |
Prognostic value of C-reactive protein/albumin ratio in hypertensive COVID-19 patients |
İbrahim Halil Özdemir, Bülent Özlek, Mehmet Burak Özen, Ramazan Gündüz, Nurullah Çetin, Eda Özlek, et al. (+2) Bekir Serhat Yıldız, Ali Rıza Bilge |
| 7 |
[GO] |
2021―Mai―06 |
The effect of RAAS inhibitors on acute hypoxemic respiratory failure and in-hospital mortality in the hypertensive Covid-19 patients |
Abdurrahman Akyüz, Ferhat Işık, Burhan Aslan, Murat Çap, İlyas Kaya, Özgür Atlı, et al. (+11) Ümit İnci, Ercan Taştan, Adem Aktan, Önder Bilge, Metin Okşul, Emre Aydın, Zülküf Karahan, Derya Deniz Altıntaş, Rojhat Altındağ, Mehmet Şahin Adıyaman, Bernas Altıntaş |
| 8 |
[GO] |
2021―Feb―17 |
CT visual quantitative evaluation of hypertensive patients with coronavirus disease (COVID-19): Potential influence of angiotensin converting enzyme inhibitors / angiotensin receptor blockers on severity of lung involvement |
Cesur Samanci, Bengu Saylan, Gokce Gulsen, Yuksel Akkaya, Melike Yesildal, Sinem Akkaya Isik, Fethi Emre Ustabasioglu |
| 9 |
[GO] |
2020―Dez―26 |
Association of ACEI/ARB, inflammatory cytokines, and antiviral drugs with liver dysfunction in patients with hypertension and COVID-19 |
Dong Xiang, Xiuhua Ren, Qian Chen, Hengyi Yu, Xiping Li, Dong Liu |
| 10 |
[GO] |
2020―Nov―12 |
Anxiety and depression levels in Covid-19 disease and their relation to hypertension |
Baris Sensoy, Aygül Gunes, Selma Ari |
| 11 |
[GO] |
2020―Aug―24 |
Survival rate in hypertensive patients with COVID-19 |
Amir Emami, Fatemeh Javanmardi, Ali Akbari, Javad Kojuri, Hamid Bakhtiari, Tahereh Rezaei, et al. (+2) Abdolkhalegh Keshavarzi, Farshad Falahati |
| 12 |
[GO] |
2020―Jun―22 |
Is the use of ACE inb/ARBs associated with higher in-hospital mortality in Covid-19 pneumonia patients? |
Murat Selçuk, Tufan Çınar, Muhammed Keskin, Vedat Çiçek, Şahhan Kılıç, Behruz Kenan, et al. (+6) Selami Doğan, Süha Asal, Nuran Günay, Ersin Yıldırım, Ümran Keskin, Ahmet Lütfullah Orhan |
| 13 |
[GO] |
2020―Mai―14 |
Clinical characteristics of coronavirus disease 2019 (COVID-19) patients with hypertension on renin-angiotensin system inhibitors |
Xian Zhou, Jingkang Zhu, Tao Xu |
|
